Immunology

Tech round up: June 2024

Best new tech this month

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Personalised vaccines: A pioneering new immunotherapy

A look at the international trial of the world’s first personalised mRNA cancer immunotherapy for melanoma and its potential translation to other cancers and diseases.

My lab: antibodymediated autoimmune neurology

A guided tour of the Oxford Autoimmune Neurology Diagnostic Laboratory.

Vaccine for highly fatal tropical disease

In a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease.

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

Tissue grafts that escape immune system rejection

In a preclinical breakthrough, researchers have developed a technology that may one day eliminate the need for immunosuppressive drugs in transplant patients.

Fractional COVID-19 booster vaccines

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

How to measure improvement in long COVID

Researchers have reached an agreement on how to measure the severity and impact of long COVID by identifying a “Core Outcome Measure Set” (COMS).

Benefits of exercise and the immune system

A new study may offer molecular insights into the connection between exercise and inflammation.

Top